InvestorsHub Logo
Followers 52
Posts 3352
Boards Moderated 0
Alias Born 10/26/2013

Re: antihama post# 1719

Tuesday, 08/01/2017 7:45:18 AM

Tuesday, August 01, 2017 7:45:18 AM

Post# of 3283
Today's PR includes the word "Pivotal" in title. That helps erase a small concern of mine regarding whether Rolontis is approvable based on this one P3 with SPA. You must of heard me Dr. Raj.

Where I have a concern with Rolontis these days is if Dr. Raj is misstating that the second trial is only needed for EU approval. Several analysts have asked him directly what the second trial is for or whether a second trial is needed for US approval and he always stated that it’s not.